620 filings
Page 10 of 31
8-K
dvoy6fwh 668e6q1
13 Aug 20
Submission of Matters to a Vote of Security Holders
8:00am
4
pnrct7 34suwk
28 Jul 20
NeuBase Therapeutics / William Roland Mann ownership change
4:22pm
3
2dvp4q18
28 Jul 20
NeuBase Therapeutics / William Roland Mann ownership change
4:17pm
8-K
5d9m9dy
28 Jul 20
NeuBase Therapeutics Strengthens Senior Management Team with Appointment of Industry Veteran William Mann, Ph.D., MBA as Chief Operating Officer
8:16am
DEFA14A
hilc0pr3
1 Jul 20
Additional proxy soliciting materials
5:12pm
4
qijdyryae gonsl
10 Jun 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
11:50am
8-K
tph51eclcmlnk
9 Jun 20
Other Events
4:30pm
4
i14j1qztmig ocz
26 May 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:39pm
8-K
ozvte 7t58a55a74syx
14 May 20
NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter of 2020
4:06pm
4
4d248ak vvjau33x6v2
4 May 20
NeuBase Therapeutics / Dietrich A Stephan ownership change
3:25pm
4
fdw2x
4 May 20
NeuBase Therapeutics / DOV A MD GOLDSTEIN ownership change
2:18pm
4
njaybrm5vyyeze
4 May 20
NeuBase Therapeutics / Samuel Backenroth ownership change
12:28pm
4
1wrdu6l4i753z
4 May 20
NeuBase Therapeutics / ERIC I RICHMAN ownership change
9:56am
SC 13G/A
btwy4cx
1 May 20
NeuBase Therapeutics / HIRSCHMAN ORIN ownership change
4:17pm
8-K
ry94oz1
30 Apr 20
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
4:11pm
424B5
m33dr8r
29 Apr 20
Prospectus supplement for primary offering
4:21pm
8-K
8jkquie7uzl30rpc
29 Apr 20
NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock
12:00am
424B5
5w0k 5zn7v
27 Apr 20
Prospectus supplement for primary offering
4:23pm